Who should receive clozapine?
D000380:Agranulocytosis / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D003984:Dibenzazepines / Q000627:therapeutic use*; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy*; D014481:United States
D014150:Antipsychotic Agents; D003984:Dibenzazepines; D003024:Clozapine